Brief Title: Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer

PRIMARY OUTCOMES

Primary Outcome 1 - Measure:

Primary Outcome 1 - Timeframe: N/A

CONDITION

• Bladder Cancer

ELIGIBILITY

Inclusion Criteria:
* Ability of participant OR Legally Authorized Representative (LAR) to understand this study, and participant or LAR willingness to sign a written informed consent.

- * Age ≥ 18 years.

- * Histologically proven MIBC (Muscle Invasive Bladder Cancer) without metastatic disease Diagnosis.

- * Planning to undergo neoadjuvant chemotherapy and radical cystectomy for MIBC
Exclusion Criteria:
* No prior systemic chemotherapy for MIBC.

- * Cannot be simultaneously enrolled in any therapeutic clinical trial, unless receiving standard neoadjuvant chemotherapy on said clinical trial.

- * Any oral or cognitive pathology impairing the ability to perform taste testing procedures.

- * No other known malignancy within previous 2 years with the following EXCEPTIONS: Low-grade prostate cancer on active surveillance, CLL on surveillance / observation, non-melanoma skin cancers.

- * No psychiatric illness/social situations that would limit compliance with study requirements.

Gender: All

Minimum Age: 18 Years

Maximum Age: N/A

Healthy Volunteers: No

OFFICIAL INFORMATION

Name: Elizabeth Wulff- Burchfield, MD

Role: Principal Investigator

Affiliation: The University of Kansas Cancer Center

Overall Contact

Name: N/A

Phone: N/A

Email: N/A

LOCATION